• Tropheryma whipplei, Molecular
  • HLA-B27 Genotyping, Ankylosing Spondylitis
  • Cancer Antigen (CA) 19-9, Peritoneal Fluid
  • Rickettsia Antibody Panel, IgG and IgM
  • MDMA, Urine
  • Antithrombin Activity
  • Hemoglobin A1c
  • Electrophoresis, Protein, CSF
  • HLA Class II DR, DQ and DP Genotyping (HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1)
  • Squamous Cell Carcinoma Antigen (SSCA)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /X-Inactivation (XIST), Xq13.2 Deletion
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

X-Inactivation (XIST), Xq13.2 Deletion
Medical Test

References
Access to X-Inactivation (XIST), Xq13.2 Deletion is restricted.